RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
February 21, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients...
RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock
February 14, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. (“RxSight®”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
February 08, 2023 00:45 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. (“RxSight”), an ophthalmic medical device company dedicated to improving the vision of patients following...
RxSight, Inc. Announces Proposed Public Offering of Common Stock
February 07, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results
January 08, 2023 16:00 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Jan. 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
December 28, 2022 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...
RxSight, Inc. Reports Third Quarter 2022 Financial Results
November 07, 2022 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported...
RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022
October 24, 2022 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
August 24, 2022 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program
August 08, 2022 16:10 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...